AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Worldwide Industry for Bone Cancer Drugs to 2024 - Key Drivers, Challenges and Trends - ResearchAndMarkets.com

December 22, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Dec 22, 2020--

The “Global Bone Cancer Drugs Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering.

The publisher has been monitoring the bone cancer drugs market and it is poised to grow by $911.76 million during 2020-2024, progressing at a CAGR of 5% during the forecast period.

ADVERTISEMENT

The reports on the bone cancer drugs market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing risk factors, the strong prevalence of osteosarcoma in younger patients, and increasing strategic alliances. In addition, growing risk factors is anticipated to boost the growth of the market as well.

The bone cancer drugs market analysis includes type segment and geographical landscapes. This study identifies novel drug delivery as one of the prime reasons driving the bone cancer drugs market growth during the next few years. Also, the advent of targeted therapies and strong research grants will lead to sizable demand in the market.

Companies Mentioned

  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.

The bone cancer drugs market report covers the following areas:

  • Bone cancer drugs market sizing
  • Bone cancer drugs market forecast
  • Bone cancer drugs market industry analysis

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

ADVERTISEMENT

Key Topics Covered:

1. Executive Summary

  • Market Overview

2. Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

3. Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

4. Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

5. Market Segmentation by Indication

  • Market segments
  • Comparison by indication
  • Osteosarcoma - Market size and forecast 2019-2024
  • Ewing’s sarcoma - Market size and forecast 2019-2024
  • Chondrosarcoma - Market size and forecast 2019-2024
  • Other bone cancers - Market size and forecast 2019-2024
  • Market opportunity by Indication

6. Customer landscape

7. Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

8. Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive Scenario

9. Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Amgen Inc.
  • Baxter International Inc.
  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.

10. Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/vx91cg

View source version on businesswire.com:https://www.businesswire.com/news/home/20201222005459/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/22/2020 10:22 AM/DISC: 12/22/2020 10:22 AM

http://www.businesswire.com/news/home/20201222005459/en